Phathom Pharmaceuticals Inc banner

Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 11.65 USD -1.94% Market Closed
Market Cap: $907.8m

Profitability Summary

Phathom Pharmaceuticals Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Phathom Pharmaceuticals Inc

Margins Comparison
Phathom Pharmaceuticals Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
830.5m USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
965.7B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
594B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
291.5B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
236.4B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
242.5B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
303.7B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
152.2B USD
Loading...
Loading...
Loading...
UK
GSK plc
XETRA:GS71
105.9B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Phathom Pharmaceuticals Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
830.5m USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
965.7B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
594B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
291.5B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
236.4B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
242.5B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
303.7B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
152.2B USD
Loading...
Loading...
Loading...
Loading...
UK
GSK plc
XETRA:GS71
105.9B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Phathom Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate